Promising clinical studies surrounding the medication Retatrutide , specifically the 120mg formulation branded as ZPHC, reveal a considerable benefit on weight reduction and associated metabolic conditions . Experts believe that this innovative acting , targeting both GLP-1 and GIP receptors , has the potential to provide a substantial improvement